Moderna Total Long-Term Assets 2017-2024 | MRNA

Moderna total long-term assets for the quarter ending September 30, 2024 were $6.137B, a 29.06% decline year-over-year.

  • Moderna total long-term assets for 2023 were $8.101B, a 34.81% decline from 2022.
  • Moderna total long-term assets for 2022 were $12.427B, a 44.53% increase from 2021.
  • Moderna total long-term assets for 2021 were $8.598B, a 727.53% increase from 2020.

Moderna Total Long-Term Assets 2017-2024 | MRNA

  • Moderna total long-term assets for 2023 were $8.101B, a 34.81% decline from 2022.
  • Moderna total long-term assets for 2022 were $12.427B, a 44.53% increase from 2021.
  • Moderna total long-term assets for 2021 were $8.598B, a 727.53% increase from 2020.